OPTIMIZATION OF PROPHYLAXIS OF HYPERCOAGULATION COMPLICATIONS IN ONCOLOGICAL SURGERY
https://doi.org/10.24884/0042-4625-2014-173-5-12-15
Abstract
The authors investigate the results of prophylaxis of venous thromboembolic complications (VTC) during 24 years in oncological surgery. The multicentric study shows that common frequency of occurrence of such VTC was reduced due to period of routine prophylaxis of VTC to 3,4%. The strategy of active revision and escalation of preventive measures in the third period of study in comparison with the second period resulted in the decrease of VTC. Patients with moderate risk degree had the results from 3,2% to 1%, patients with high risk degree moved from 4,1% to 1,3%. The fatal thromboembolism of the lung artery was 0,1%.
About the Authors
A. M. Karsanov
North-Ossetian State Medical Academy
Russian Federation
Russian Federation
S. S. Maskin
Volgograd State Medical University
Russian Federation
Russian Federation
A. A. Kul’Chiev
North-Ossetian State Medical Academy
Russian Federation
Russian Federation
F. D. Karsanova
Union station hospital
Russian Federation
Russian Federation
T. R. Karaev
North-Ossetian State Medical Academy
Russian Federation
Russian Federation
G. K. Mil’Dzikhov
North-Ossetian State Medical Academy; Union station hospital
Russian Federation
Russian Federation
References
1. Баркаган З. С., Момот А. П. Диагностика и контролируемая терапия нарушений гемостаза. М., 2008. 290 с.
2. Воробьева Н. М., Панченко Е. П., Андрияшкин В. В. и др. Факторы, определяющие эффективность антикоагулянтной терапии у больных с венозными тромбоэмболическими осложнениями // Флебология. 2010. № 2. C. 13-20.
3. Кириенко А. И., Леонтьев С. Г., Гусев Л. Л. и др. Комплексное лечение больных с острым венозным тромбозом // Флебология. 2012. № 2. C. 40-44.
4. Пчелинцева Т. А., Лопырева О. И., Шишина Р. Н. Оценка плазменного гемостаза у больных с послеоперационным венозным тромбозом // Флебология. 2011. № 3. C. 29-31.
5. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений // Флебология. 2010; № 1. C. 2-37.
6. Bergmann J. F., Cohen A. T., Tapson V. F. et al. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey // Thromb. Haemost. 2010. Vol. 103, № 4. P. 736-748.
7. Chew H. K., Wun T., Harvey D. J. et al. Incidence of venous thromboembolism and the impact on survival in breast cancer patients // J. Clin. Oncol. 2007. Vol. 25, № 1. P. 70-76.
8. Gallieni M., Pittiruti M., Biffi R. Vascular access in oncology patients // CA Cancer. J. Clin. 2008. Vol. 58, № 6. P. 323-346.
9. Hanna N., Bikov K. A., McNally D. et al. Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer // Oncologist. 2012. Vol. 17, № 9. P. 1191- 1197.
10. Kakkar A. K., Cohen A. T., Tapson V.F. et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients // Ann. Surg. 2010. Vol. 251, № 2. P. 330-338.
11. Lyman G. H., Khorana A. A., Kuderer N. M. et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology practice guideline update // J. Clin. Oncol. 2013. Vol. 31, № 17. P. 2189-2204.
12. Mandala M., Falanga А., Roila F. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines // Ann. Oncol. 2011. Vol. 22, № 6. P. 85-92.
Review
For citations:
Karsanov A.M., Maskin S.S., Kul’Chiev A.A., Karsanova F.D., Karaev T.R., Mil’Dzikhov G.K. OPTIMIZATION OF PROPHYLAXIS OF HYPERCOAGULATION COMPLICATIONS IN ONCOLOGICAL SURGERY. Grekov's Bulletin of Surgery. 2014;173(5):12-15. (In Russ.) https://doi.org/10.24884/0042-4625-2014-173-5-12-15
Views:
337
Email this article 